FREE SHIPPING ON ORDERS OVER $30 (U. S. Addresses)
{"id":7026014716063,"title":"Parke, Davis \u0026 Company","handle":"parke-davis-company","description":"\u003cmeta charset=\"utf-8\"\u003e\n\u003ch5\u003eProduct Details\u003c\/h5\u003e\n\u003cp\u003eBeautifully engraved antique stock certificate from Parke, Davis \u0026amp; Company dating back to the 1920's. This document, which is signed by the company President and Secretary, was a printed by the Columbian Bank Note Company, and measures approximately 10 3\/4\" (w) by 7 1\/2\" (h).\u003cbr\u003e\u003cbr\u003eThe vignette features the company's original logo, with the motto \"Medicamenta Vera,\" which means \"True Medicine.\"\u003c\/p\u003e\n\u003ch5 style=\"text-align: left;\"\u003eImages\u003c\/h5\u003e\n\u003cp style=\"text-align: left;\"\u003eYou will receive the exact certificate pictured.\u003c\/p\u003e\n\u003ch5\u003eHistorical Context\u003c\/h5\u003e\n\u003cp\u003e\u003ca href=\"https:\/\/ghostsofwallstreet.com\/collections\/parke-davis-company\"\u003e\u003cstrong\u003eParke, Davis and Company\u003c\/strong\u003e\u003c\/a\u003e was founded in \u003ca href=\"https:\/\/ghostsofwallstreet.com\/collections\/detroit-michigan\"\u003e\u003cstrong\u003eDetroit, Michigan\u003c\/strong\u003e\u003c\/a\u003e by Dr. Samuel P. Duffield, a physician and pharmacist. In 1860, Dr. Duffield owned a small drugstore at the corner of Gratiot and Woodward Avenues. Dr. Duffield made a variety of pharmaceutical preparations, including Hoffman’s anodyne and mercurial ointment, but was overwhelmed by the operations of the business.\u003cbr\u003e\u003cbr\u003eDr. Duffield and Hervey Coke Parke formed a partnership in October 1866, with George S. Davis becoming a third partner in 1867. Parke was a businessman looking for business opportunities and Davis, an ambitious man with skills in sales. Duffield withdrew in 1869 because of poor health and an interest in practicing medicine. The partnership adopted the name Parke, Davis or Parke-Davis in 1871, and was formally incorporated as Parke, Davis \u0026amp; Company in 1875.\u003cbr\u003e\u003cbr\u003eIn 1871, the company sent expeditions to Central and South America and the West Indies in search of medicinal plants. The company produced an herbal laxative drug Cascara found from Native Americans in the Pacific Northwest.\u003cbr\u003e\u003cbr\u003eIt was once the world's largest \u003ca href=\"https:\/\/ghostsofwallstreet.com\/collections\/drug-pharmaceutical\"\u003e\u003cstrong\u003epharmaceutical company\u003c\/strong\u003e\u003c\/a\u003e and is credited with building the first modern pharmaceutical laboratory and developing the first systematic methods of performing clinical trials of new medications. The Parke-Davis Research Laboratory is a National Historic Landmark; the surrounding Parke-Davis and Company Pharmaceutical Company Plant is on the National Register of Historic Places. The production facility on Parkdale Road in what was then Avon Township, Michigan (site now in Rochester, Michigan) was also a landmark in that vicinity and is now used by PAR Pharmaceuticals.\u003cbr\u003e\u003cbr\u003eIn the 1950s, Parke-Davis employed Jonas Salk as a consultant on vaccine adjuvants. Parke-Davis was also involved in manufacturing the polio vaccine. It took Salk much effort to convince Parke-Davis to follow his production protocols exactly. For about six months Parke-Davis had the exclusive contract to produce the vaccine for field trials but in February 1954 the National Foundation for the prevention of Polio reneged on the contract and opened vaccine production to other companies as well.\u003cbr\u003e\u003cbr\u003eIn the case of Franklin v. Parke-Davis (2002), the company was accused of illegal marketing practices, including the promotion of off-label uses of its anticonvulsant medication Neurontin. The drug had only been approved for use in patients with epilepsy, but in 2001 over 80% of its $1.8 billion in sales were for indications unapproved by the United States Food and Drug Administration. In 2004, \u003ca href=\"https:\/\/ghostsofwallstreet.com\/collections\/pfizer\"\u003e\u003cstrong\u003ePfizer\u003c\/strong\u003e\u003c\/a\u003e \"admitted that Parke-Davis aggressively marketed Neurontin by illicit means for unrelated conditions including bipolar disorder, pain, migraine headaches, and drug and alcohol withdrawal\", and consented to $430 million in penalties although it claimed the violations originated in 1996, well before Pfizer's acquisition of \u003ca href=\"https:\/\/ghostsofwallstreet.com\/collections\/warner-lambert\"\u003e\u003cstrong\u003eWarner-Lambert\u003c\/strong\u003e\u003c\/a\u003e (which acquired Parke, Davis \u0026amp; Company in 1970).\u003cbr\u003e\u003cbr\u003e\u003cspan style=\"text-decoration: underline;\"\u003e\u003cem\u003eProducts\u003c\/em\u003e\u003c\/span\u003e\u003cbr\u003e\u003cbr\u003eOne of Parke-Davis' early products was an amylase isolated from Aspergillus oryzae by Dr. Jōkichi Takamine. The enzyme was originally intended for use in distilleries but was more successfully marketed as \"Taka-diastase\" for dyspepsia.\u003cbr\u003e\u003cbr\u003eAlso, Parke-Davis distributed Coley's toxins, the first cancer vaccine, which was developed by William Coley to treat osteosarcoma. Additionally, the company entered into a distribution agreement with the Inoculation Department of St Mary's (London) and distributed a number of vaccines for infectious diseases and even acne and cancer.\u003cbr\u003e\u003cbr\u003eAnother of the company's products developed by Takamine was a pure form of adrenaline. The compound was patented in 1900 and trademarked as \"Adrenalin.\" Because of the similarity of this name to \"Adrenaline,\" the use of the alternative name \"epinephrine\" for generics was mandated in the United States and is used to this day. Parke-Davis filed a lawsuit against H. K. Mulford Company alleging infringement of its Adrenalin patents. The ruling in favor of Parke-Davis by Judge Learned Hand is considered crucial to modern patent law.\u003cbr\u003e\u003cbr\u003eLike Bayer with heroin; before the criminalization of cocaine, the drug was sold by Parke-Davis in various forms, including cigarettes, powder, and even a cocaine mixture that could be injected directly into the user’s veins with the included needle. The company promised that its cocaine products would \"supply the place of food, make the coward brave, the silent eloquent and ... render the sufferer insensitive to pain.\" In October 1915, Aleister Crowley, author of Diary of a Drug Fiend and The Confessions of Aleister Crowley, stopped by Parke-Davis in Detroit, where, according to Crowley, the cooperation was complete. \"[They] were kind enough to interest themselves in my researches in Anhalonium lewinii (peyote) and made me some special preparations on the lines indicated by my experience which proved greatly superior to previous preparations.\" Parke-Davis also was the original manufacturer and patent holder of phencyclidine (PCP) which is currently listed as a Schedule II drug in the United States. It also developed Ketalar (ketamine hydrochloride), a general anesthetic and dissociative drug, in 1962.\u003c\/p\u003e","published_at":"2021-08-23T15:30:57-04:00","created_at":"2021-08-23T15:15:28-04:00","vendor":"Ghosts of Wall Street","type":"Stock Certificates","tags":["*P*","1920s","Consumer Products","Date_1920s","Detroit","Drug \u0026 Pharmaceutical","Famous Companies","Michigan","Parke Davis \u0026 Company","Pfizer","Price_$10 - $19.99","Region_Midwest","Warner-Lambert"],"price":1900,"price_min":1900,"price_max":1900,"available":true,"price_varies":false,"compare_at_price":null,"compare_at_price_min":0,"compare_at_price_max":0,"compare_at_price_varies":false,"variants":[{"id":40871974469791,"title":"Default Title","option1":"Default Title","option2":null,"option3":null,"sku":"8603","requires_shipping":true,"taxable":true,"featured_image":null,"available":true,"name":"Parke, Davis \u0026 Company","public_title":null,"options":["Default Title"],"price":1900,"weight":7,"compare_at_price":null,"inventory_management":"shopify","barcode":"","requires_selling_plan":false,"selling_plan_allocations":[]}],"images":["\/\/cdn.shopify.com\/s\/files\/1\/0055\/6253\/1904\/products\/8603.png?v=1629746973","\/\/cdn.shopify.com\/s\/files\/1\/0055\/6253\/1904\/products\/8603vign.png?v=1629746979"],"featured_image":"\/\/cdn.shopify.com\/s\/files\/1\/0055\/6253\/1904\/products\/8603.png?v=1629746973","options":["Title"],"media":[{"alt":"Parke, Davis \u0026 Company Stock Certificate","id":22934613065887,"position":1,"preview_image":{"aspect_ratio":1.466,"height":1023,"width":1500,"src":"https:\/\/cdn.shopify.com\/s\/files\/1\/0055\/6253\/1904\/products\/8603.png?v=1629746973"},"aspect_ratio":1.466,"height":1023,"media_type":"image","src":"https:\/\/cdn.shopify.com\/s\/files\/1\/0055\/6253\/1904\/products\/8603.png?v=1629746973","width":1500},{"alt":"Parke, Davis \u0026 Company Stock Certificate","id":22934613098655,"position":2,"preview_image":{"aspect_ratio":1.894,"height":725,"width":1373,"src":"https:\/\/cdn.shopify.com\/s\/files\/1\/0055\/6253\/1904\/products\/8603vign.png?v=1629746979"},"aspect_ratio":1.894,"height":725,"media_type":"image","src":"https:\/\/cdn.shopify.com\/s\/files\/1\/0055\/6253\/1904\/products\/8603vign.png?v=1629746979","width":1373}],"requires_selling_plan":false,"selling_plan_groups":[],"content":"\u003cmeta charset=\"utf-8\"\u003e\n\u003ch5\u003eProduct Details\u003c\/h5\u003e\n\u003cp\u003eBeautifully engraved antique stock certificate from Parke, Davis \u0026amp; Company dating back to the 1920's. This document, which is signed by the company President and Secretary, was a printed by the Columbian Bank Note Company, and measures approximately 10 3\/4\" (w) by 7 1\/2\" (h).\u003cbr\u003e\u003cbr\u003eThe vignette features the company's original logo, with the motto \"Medicamenta Vera,\" which means \"True Medicine.\"\u003c\/p\u003e\n\u003ch5 style=\"text-align: left;\"\u003eImages\u003c\/h5\u003e\n\u003cp style=\"text-align: left;\"\u003eYou will receive the exact certificate pictured.\u003c\/p\u003e\n\u003ch5\u003eHistorical Context\u003c\/h5\u003e\n\u003cp\u003e\u003ca href=\"https:\/\/ghostsofwallstreet.com\/collections\/parke-davis-company\"\u003e\u003cstrong\u003eParke, Davis and Company\u003c\/strong\u003e\u003c\/a\u003e was founded in \u003ca href=\"https:\/\/ghostsofwallstreet.com\/collections\/detroit-michigan\"\u003e\u003cstrong\u003eDetroit, Michigan\u003c\/strong\u003e\u003c\/a\u003e by Dr. Samuel P. Duffield, a physician and pharmacist. In 1860, Dr. Duffield owned a small drugstore at the corner of Gratiot and Woodward Avenues. Dr. Duffield made a variety of pharmaceutical preparations, including Hoffman’s anodyne and mercurial ointment, but was overwhelmed by the operations of the business.\u003cbr\u003e\u003cbr\u003eDr. Duffield and Hervey Coke Parke formed a partnership in October 1866, with George S. Davis becoming a third partner in 1867. Parke was a businessman looking for business opportunities and Davis, an ambitious man with skills in sales. Duffield withdrew in 1869 because of poor health and an interest in practicing medicine. The partnership adopted the name Parke, Davis or Parke-Davis in 1871, and was formally incorporated as Parke, Davis \u0026amp; Company in 1875.\u003cbr\u003e\u003cbr\u003eIn 1871, the company sent expeditions to Central and South America and the West Indies in search of medicinal plants. The company produced an herbal laxative drug Cascara found from Native Americans in the Pacific Northwest.\u003cbr\u003e\u003cbr\u003eIt was once the world's largest \u003ca href=\"https:\/\/ghostsofwallstreet.com\/collections\/drug-pharmaceutical\"\u003e\u003cstrong\u003epharmaceutical company\u003c\/strong\u003e\u003c\/a\u003e and is credited with building the first modern pharmaceutical laboratory and developing the first systematic methods of performing clinical trials of new medications. The Parke-Davis Research Laboratory is a National Historic Landmark; the surrounding Parke-Davis and Company Pharmaceutical Company Plant is on the National Register of Historic Places. The production facility on Parkdale Road in what was then Avon Township, Michigan (site now in Rochester, Michigan) was also a landmark in that vicinity and is now used by PAR Pharmaceuticals.\u003cbr\u003e\u003cbr\u003eIn the 1950s, Parke-Davis employed Jonas Salk as a consultant on vaccine adjuvants. Parke-Davis was also involved in manufacturing the polio vaccine. It took Salk much effort to convince Parke-Davis to follow his production protocols exactly. For about six months Parke-Davis had the exclusive contract to produce the vaccine for field trials but in February 1954 the National Foundation for the prevention of Polio reneged on the contract and opened vaccine production to other companies as well.\u003cbr\u003e\u003cbr\u003eIn the case of Franklin v. Parke-Davis (2002), the company was accused of illegal marketing practices, including the promotion of off-label uses of its anticonvulsant medication Neurontin. The drug had only been approved for use in patients with epilepsy, but in 2001 over 80% of its $1.8 billion in sales were for indications unapproved by the United States Food and Drug Administration. In 2004, \u003ca href=\"https:\/\/ghostsofwallstreet.com\/collections\/pfizer\"\u003e\u003cstrong\u003ePfizer\u003c\/strong\u003e\u003c\/a\u003e \"admitted that Parke-Davis aggressively marketed Neurontin by illicit means for unrelated conditions including bipolar disorder, pain, migraine headaches, and drug and alcohol withdrawal\", and consented to $430 million in penalties although it claimed the violations originated in 1996, well before Pfizer's acquisition of \u003ca href=\"https:\/\/ghostsofwallstreet.com\/collections\/warner-lambert\"\u003e\u003cstrong\u003eWarner-Lambert\u003c\/strong\u003e\u003c\/a\u003e (which acquired Parke, Davis \u0026amp; Company in 1970).\u003cbr\u003e\u003cbr\u003e\u003cspan style=\"text-decoration: underline;\"\u003e\u003cem\u003eProducts\u003c\/em\u003e\u003c\/span\u003e\u003cbr\u003e\u003cbr\u003eOne of Parke-Davis' early products was an amylase isolated from Aspergillus oryzae by Dr. Jōkichi Takamine. The enzyme was originally intended for use in distilleries but was more successfully marketed as \"Taka-diastase\" for dyspepsia.\u003cbr\u003e\u003cbr\u003eAlso, Parke-Davis distributed Coley's toxins, the first cancer vaccine, which was developed by William Coley to treat osteosarcoma. Additionally, the company entered into a distribution agreement with the Inoculation Department of St Mary's (London) and distributed a number of vaccines for infectious diseases and even acne and cancer.\u003cbr\u003e\u003cbr\u003eAnother of the company's products developed by Takamine was a pure form of adrenaline. The compound was patented in 1900 and trademarked as \"Adrenalin.\" Because of the similarity of this name to \"Adrenaline,\" the use of the alternative name \"epinephrine\" for generics was mandated in the United States and is used to this day. Parke-Davis filed a lawsuit against H. K. Mulford Company alleging infringement of its Adrenalin patents. The ruling in favor of Parke-Davis by Judge Learned Hand is considered crucial to modern patent law.\u003cbr\u003e\u003cbr\u003eLike Bayer with heroin; before the criminalization of cocaine, the drug was sold by Parke-Davis in various forms, including cigarettes, powder, and even a cocaine mixture that could be injected directly into the user’s veins with the included needle. The company promised that its cocaine products would \"supply the place of food, make the coward brave, the silent eloquent and ... render the sufferer insensitive to pain.\" In October 1915, Aleister Crowley, author of Diary of a Drug Fiend and The Confessions of Aleister Crowley, stopped by Parke-Davis in Detroit, where, according to Crowley, the cooperation was complete. \"[They] were kind enough to interest themselves in my researches in Anhalonium lewinii (peyote) and made me some special preparations on the lines indicated by my experience which proved greatly superior to previous preparations.\" Parke-Davis also was the original manufacturer and patent holder of phencyclidine (PCP) which is currently listed as a Schedule II drug in the United States. It also developed Ketalar (ketamine hydrochloride), a general anesthetic and dissociative drug, in 1962.\u003c\/p\u003e"}

Parke, Davis & Company

$19.00
Maximum quantity available reached.
Stock Number: 8603
Product Details

Beautifully engraved antique stock certificate from Parke, Davis & Company dating back to the 1920's. This document, which is signed by the company President and Secretary, was a printed by the Columbian Bank Note Company, and measures approximately 10 3/4" (w) by 7 1/2" (h).

The vignette features the company's original logo, with the motto "Medicamenta Vera," which means "True Medicine."

Images

You will receive the exact certificate pictured.

Historical Context

Parke, Davis and Company was founded in Detroit, Michigan by Dr. Samuel P. Duffield, a physician and pharmacist. In 1860, Dr. Duffield owned a small drugstore at the corner of Gratiot and Woodward Avenues. Dr. Duffield made a variety of pharmaceutical preparations, including Hoffman’s anodyne and mercurial ointment, but was overwhelmed by the operations of the business.

Dr. Duffield and Hervey Coke Parke formed a partnership in October 1866, with George S. Davis becoming a third partner in 1867. Parke was a businessman looking for business opportunities and Davis, an ambitious man with skills in sales. Duffield withdrew in 1869 because of poor health and an interest in practicing medicine. The partnership adopted the name Parke, Davis or Parke-Davis in 1871, and was formally incorporated as Parke, Davis & Company in 1875.

In 1871, the company sent expeditions to Central and South America and the West Indies in search of medicinal plants. The company produced an herbal laxative drug Cascara found from Native Americans in the Pacific Northwest.

It was once the world's largest pharmaceutical company and is credited with building the first modern pharmaceutical laboratory and developing the first systematic methods of performing clinical trials of new medications. The Parke-Davis Research Laboratory is a National Historic Landmark; the surrounding Parke-Davis and Company Pharmaceutical Company Plant is on the National Register of Historic Places. The production facility on Parkdale Road in what was then Avon Township, Michigan (site now in Rochester, Michigan) was also a landmark in that vicinity and is now used by PAR Pharmaceuticals.

In the 1950s, Parke-Davis employed Jonas Salk as a consultant on vaccine adjuvants. Parke-Davis was also involved in manufacturing the polio vaccine. It took Salk much effort to convince Parke-Davis to follow his production protocols exactly. For about six months Parke-Davis had the exclusive contract to produce the vaccine for field trials but in February 1954 the National Foundation for the prevention of Polio reneged on the contract and opened vaccine production to other companies as well.

In the case of Franklin v. Parke-Davis (2002), the company was accused of illegal marketing practices, including the promotion of off-label uses of its anticonvulsant medication Neurontin. The drug had only been approved for use in patients with epilepsy, but in 2001 over 80% of its $1.8 billion in sales were for indications unapproved by the United States Food and Drug Administration. In 2004, Pfizer "admitted that Parke-Davis aggressively marketed Neurontin by illicit means for unrelated conditions including bipolar disorder, pain, migraine headaches, and drug and alcohol withdrawal", and consented to $430 million in penalties although it claimed the violations originated in 1996, well before Pfizer's acquisition of Warner-Lambert (which acquired Parke, Davis & Company in 1970).

Products

One of Parke-Davis' early products was an amylase isolated from Aspergillus oryzae by Dr. Jōkichi Takamine. The enzyme was originally intended for use in distilleries but was more successfully marketed as "Taka-diastase" for dyspepsia.

Also, Parke-Davis distributed Coley's toxins, the first cancer vaccine, which was developed by William Coley to treat osteosarcoma. Additionally, the company entered into a distribution agreement with the Inoculation Department of St Mary's (London) and distributed a number of vaccines for infectious diseases and even acne and cancer.

Another of the company's products developed by Takamine was a pure form of adrenaline. The compound was patented in 1900 and trademarked as "Adrenalin." Because of the similarity of this name to "Adrenaline," the use of the alternative name "epinephrine" for generics was mandated in the United States and is used to this day. Parke-Davis filed a lawsuit against H. K. Mulford Company alleging infringement of its Adrenalin patents. The ruling in favor of Parke-Davis by Judge Learned Hand is considered crucial to modern patent law.

Like Bayer with heroin; before the criminalization of cocaine, the drug was sold by Parke-Davis in various forms, including cigarettes, powder, and even a cocaine mixture that could be injected directly into the user’s veins with the included needle. The company promised that its cocaine products would "supply the place of food, make the coward brave, the silent eloquent and ... render the sufferer insensitive to pain." In October 1915, Aleister Crowley, author of Diary of a Drug Fiend and The Confessions of Aleister Crowley, stopped by Parke-Davis in Detroit, where, according to Crowley, the cooperation was complete. "[They] were kind enough to interest themselves in my researches in Anhalonium lewinii (peyote) and made me some special preparations on the lines indicated by my experience which proved greatly superior to previous preparations." Parke-Davis also was the original manufacturer and patent holder of phencyclidine (PCP) which is currently listed as a Schedule II drug in the United States. It also developed Ketalar (ketamine hydrochloride), a general anesthetic and dissociative drug, in 1962.

You may also like...